Huh et al. screened the expression of 13 factors that may affect the efficacy of preoperative CCRT in 123 LARC patients and found that the up-regulation of CD44 expression in tumor tissues before treatment predicted poor tumor regression [18]. This evidence concerns the gene CD44 and neoplasm.